Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Masuda K, Ono A, Aikata H, Kawaoka T, et al. Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. J Gastroenterol 2017 May 29. doi: 10.1007/s00535-017-1352.
PMID: 28555325

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016